CNR1
CNR1 (cannabinoid receptor 1, also known as CB1, CB-R, CB1A, CANN6 and CNR) is a G protein-coupled receptor that binds 2-arachidonoylglycerol (2-AG) and mediates the central nervous system effects of cannabinoids such as delta-9-tetrahydrocannabinol. Browse Assay Genie's current range of CNR1 research reagents below, or read on for the biology behind the target.
CNR1 is a cannabinoid receptor that belongs to the G protein-coupled receptor 1 family. As a member of the guanine-nucleotide-binding protein (G-protein) coupled receptor group, it inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. UniProt annotates the receptor as binding 2-arachidonoylglycerol (2-AG) with high affinity. The effect of 2-AG depends on the isoform: in assays measuring GTP binding to membranes, 2-AG acts as an inverse agonist on isoform 3, in contrast to its effect on isoform 1.
The CNR1 gene encodes one of two cannabinoid receptors, the other being CNR2. The cannabinoids, principally delta-9-tetrahydrocannabinol and its synthetic analogues, are the psychoactive ingredients of marijuana. Both receptors have been implicated in the cannabinoid-induced CNS effects, including alterations in mood and cognition, experienced by users of marijuana. Multiple transcript variants of the gene encode two different protein isoforms. UniProt records the protein at the cell membrane and in membrane rafts, and also at the outer mitochondrial membrane, in axonal projections and at the presynapse.
The receptor is listed by HGNC in the cannabinoid receptors gene group, under the approved name cannabinoid receptor 1, with the previous name cannabinoid receptor 1 (brain). Alternative symbols found in the literature include CB1, CB-R, CB1A, CB1K5, CANN6 and CNR. Its signalling through G proteins and its presynaptic localisation make the CNR1 protein a frequent subject in studies of cannabinoid pharmacology and neuronal signalling.
CNR1 mediates responses to delta-9-tetrahydrocannabinol and synthetic analogues, so it is central to work on how cannabinoids act at the molecular level.
The receptor is involved in cannabinoid-induced CNS effects, including changes in mood and cognition, and is found in axons and at the presynapse.
As a G protein-coupled receptor that inhibits adenylate cyclase in a pertussis toxin-sensitive manner, CNR1 is used to study G-protein signalling mechanisms.
CNR1 binds the endogenous ligand 2-AG with high affinity, with isoform-dependent agonist or inverse agonist behaviour, informing research into endocannabinoid signalling.
CNR1 is a G protein-coupled receptor for cannabinoids. It inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner and binds 2-arachidonoylglycerol with high affinity. It contributes to the CNS effects of cannabinoids, including changes in mood and cognition.
CNR1 is also called cannabinoid receptor 1, CB1, CB-R, CB1A, CB1K5, CANN6 and CNR; an earlier HGNC name was cannabinoid receptor 1 (brain). Multiple transcript variants encode two protein isoforms, and 2-AG acts as an inverse agonist on isoform 3 in GTP-binding assays, unlike on isoform 1.
CNR1 is one of two cannabinoid receptors, the other being CNR2, and both are G protein-coupled receptors. They are involved in the CNS effects of delta-9-tetrahydrocannabinol, the principal psychoactive ingredient of marijuana. A rat ortholog, Cnr1, is listed; check the datasheet of any product for its validated reactivity.
Other cannabinoid receptors, endocannabinoid pathway proteins and G-protein signalling targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P21554; product specifications from Assay Genie datasheets.